newsfilter
← Latest News
Business Wire·

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2020

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results for the three and nine months ended September 30, 2020.